Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs. Midazolam in Bipolar Depression
NCT01944293Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2013
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in bipolar disorder (BD), sponsored by New York State Psychiatric Institute. Started Sep 2013; status: completed.
02
Drugs
ketamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01944293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01944293.